So long as the research has a conclusion, it's not a failure. We learned something. There may be something to be said for whether or not the research is a worthy topic, but that's a different conversation.
There is going to be AT LEAST a whole generation of loss of progress at this point.
Everything is going to slowly crawl to a stop
and it's not an accident but by design, it's right out of Project2025
https://www.science.org/content/article/nih-ban-renewing-sen...
https://www.npr.org/sections/goats-and-soda/2025/02/27/g-s1-...
(Not that polices to reduce the cost to Americans, especially relative to foreign markets, ought to be unpopular)
Are you implying the NIH is "stultified and corrupt"?
If so, care to back that claim up?
So no, not all things government does can be replaced by the private sector, for reasons of game theory.
Trying to fix the world with a sledgehammer.
That's not true.
> If a company fires 100 employees and certain operations stop functioning, they may hire back 10 employees and reassess
How likely is it that 10 employees come back? How likely is it that critical institutional knowledge is lost forever?
> The result is a company that functions just as effectively as before but with fewer employees
Does it? Have you ever been through a reorg or restructuring at work? Do things ever get back to just as effective as before any time soon?
> This is an optimization of resources and efficiency
It's squandering human capitol, knowledge and reduced efficiency both in the short term and long term. It's the most expensive way to reduce your overhead. A far cry from optimization.
This makes it a non starter. Immunosuppressants are generally considered a worse quality of life than insulin treatment. That's why pancreas transplants are generally only done for type 1 diabetics if they are already on immunosuppressants.
Two examples off the top of my head: Sana recently announced islet cell transplantation without immunosuppression (press release: https://ir.sana.com/news-releases/news-release-details/sana-... ) and Vertex (ongoing trial: https://www.breakthrought1d.org/news-and-updates/vertex-laun... ).
Sort of like the role of the blood-brain barrier, or maybe a placenta.
https://stemcellres.biomedcentral.com/articles/10.1186/s1328...
[0] https://www.cancer.gov/about-cancer/causes-prevention/risk/i...
Stuff like this will never be a breakthrough until it doesn't need immunosuppressants. The best advancements in diabetes treatment will most likely continue to be on closed loop artificial pancreas systems.
You can read the section in [1] titled "Cancer prevention in humans."
> Starting from 2004, numerous studies demonstrated that rapamycin and everolimus reduced the incidence of various cancers in organ transplant patients.
[edit] In fact in addition to its use as an anti-rejection medication, rapamycin is used as chemotherapy to treat certain forms of cancer.
https://stemcellres.biomedcentral.com/articles/10.1186/s1328...
That would mitigate the cancer risk, since immunosuppression would not be required?
No, wait, just take a pill!
She was on immunosuppressants, so how long the new beta cells would last without those is still an open question. Other similar, ongoing trials are showing promising results.
A way to go until it becomes an option for humans. And then way more to go until it becomes a preferred option.
But this is great news.
edit: at least on mices for now
I used to think it was due to the pills they gave me there, or perhaps due to the bacteria (or virus?) causing some strange temporal abating of auto-immune response and regrowth of beta-cells. But seeing this is making me reconsider that (I was doubting the effect of the medicine since I took some home and took it in a healthy state but did not get the good effects).